Search clinical trials for: Adherence to oral anticoagulation

Total 476571 results

Centre Hospitalier Universitaire de Nīmes

Completed

Development of a Standardized Reference Guide for Tuning Adherence to Dispense During a Initial Pharmaceutical Consulting (CP ) to the Patient With Multiple Myeloma Oral Chemotherapy Primocure

Multiple Myeloma
Nova Scotia Health Authority
Dalhousie University; Capital Health, Canada

Terminated

Effects of Oral Iron on Postoperative Fatigue Upon Coronary Artery Bypass Graft Patients

Fatigue

Canada
Instituto Nacional de Salud Publica, Mexico
Instituto Nacional de Enfermedades Respiratorias; Instituto Nacional de Ciencias...

Completed

Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL) (TBL)

Diabetes Mellitus | Tuberculin (Skin Test) Positive

Mexico
Otsuka Pharmaceutical Europe Ltd
H. Lundbeck A/S

Unknown

Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia

Schizophrenia

Spain, Italy, France, Germany
Wuhan Asia Heart Hospital

Unknown

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy (REDUCE)

Valve Heart Disease | Anticoagulants; Increased

China
Helsinki University Central Hospital

Unknown

Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence

Diabetes Mellitus, Type 2 | Anticoagulant Drugs

Finland
University of Massachusetts, Worcester
Bristol-Myers Squibb

Completed

Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF (SUPPORT-AF)

Atrial Fibrillation | Anticoagulants | Prescribing Practices

United States
Fundació Institut de Recerca de l'Hospital de la...

Completed

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment (ORION)

Self Management of Oral Anticoagulation With VKA Therapy

Spain
Celgene

Completed

A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects

Heathy Volunteer

United States
University of California, Davis
Merck Sharp & Dohme LLC

Completed

Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study (NexTOC)

Contraception

United States
Memorial Sloan Kettering Cancer Center

Completed

Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

Sarcoma | Lung | Solid Tumor Gastrointestinal

United States
Massachusetts General Hospital

Completed

Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer

Cancer | Adherence to Medication Regime

United States
HIV Prevention Trials Network
National Institute of Allergy and Infectious Diseases (NIAID); Gilead Sciences and other collaborators

Completed

Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study

HIV

South Africa, Zimbabwe
Gynuity Health Projects
University of British Columbia; Bill and Melinda Gates Foundation; Daga Memorial... and other collaborators

Completed

Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy

Preeclampsia | Hypertension in Pregnancy

India
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

HIV Infections | HIV | Substance Abuse

Russian Federation
Institut Cancerologie de l'Ouest
Fondation ARC; University of Angers, GRANEM

Unknown

Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs (TOPTACOS)

Stage III Renal Cell Cancer | Metastatic Renal Cancer

France
Leonardo Marchini
Ivoclar Vivadent AG; Delta Dental of Iowa

Completed

Oral Hygiene Intervention Pilot Study

Gingivitis | Dental Caries

United States
Johannes Gutenberg University Mainz
Sanofi; Bayer; Boehringer Ingelheim; German Federal Ministry of Education and Research and other collaborators

Completed

Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme (thrombEVAL)

Atrial Fibrillation | Venous Thromboembolism | Anticoagulant Antagonists, Vitamin K and Other Coagulants Causing Adverse Effects in Therapeutic Use

Germany
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole

Nervous System Diseases | Schizophrenia | Mental Disorder

United States
Fundación para la Investigación del Hospital Clínico...

Completed

Periprocedural Direct Oral Anticoagulant Management (RA-ACOD)

Periprocedural Complication

Spain
Centro Hospitalar e Universitário de Coimbra, E...

Unknown

Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets (SCOOP)

Coronary Artery Disease | Saphenous Vein Graft Patency

Portugal
Yong Seog Oh

Unknown

Anticoagulation After RFCA (Reducible)

Atrial Fibrillation

Korea, Republic of
Wake Forest University Health Sciences

Completed

Preparatory Work to Assess Adherence to Oral Chemotherapy

Chronic Myeloid Leukemia

United States
Hospital Quality Foundation
Janssen Scientific Affairs, LLC; Boehringer Ingelheim; Daiichi Sankyo, Inc.; CSL... and other collaborators

Unknown

Safety of Oral Anticoagulants Registry (SOAR)

Blood Coagulation

United States
University Hospital, Montpellier

Completed

Evaluation of the Contribution of a Pre-consultation Questionnaire on the Therapeutic Education (EDUCONSULT)

Under Oral Anticoagulation Patients

France
Population Health Research Institute

Withdrawn

The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial (STOP-HARM)

Chronic Kidney Disease | Cerebrovascular Stroke | Acute Bleeding

Canada
Biotronik, Inc.

Terminated

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk (IMPACT)

Stroke | Atrial Fibrillation | Atrial Flutter | Major Bleeding | Embolism, Systemic Arterial

United States, Canada, United Kingdom, Denmark, Germany, Australia
University of Arkansas

Terminated

Is a Smartphone Application Effective as an Oral Medication Adherence Aid

Hypertension | Diabetes | Dyslipidemia

United States
University Hospital of Cologne
Bencard Allergie GmbH

Completed

Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment

Seasonal Allergic Rhinitis

Germany
Institut de Cancérologie de la Loire

Completed

Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy (PEPs HORMONO)

Breast Cancer

France
Institut de Cancérologie de la Loire
Centre Leon Berard; Hospices Civils de Lyon

Unknown

Assesment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral Chemotherapy (CHIMIO ORALE)

Neoplasm

France
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
Michigan State University
National Cancer Institute (NCI)

Completed

Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR

Melanoma | Leukemia | Breast Neoplasms | Prostatic Neoplasms | Colorectal Neoplasms

United States
University of Pennsylvania

Completed

Randomized Trial of Interventions to Improve Warfarin Adherence (WIN3)

Atrial Fibrillation | Deep Vein Thrombosis | Dilated Cardiomyopathies

United States
CytoDyn, Inc.

Withdrawn

A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence

HIV

United States
Bayer
Janssen Scientific Affairs, LLC

Completed

Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT) (BOX-DVT)

Venous Thrombosis

Belgium
Bayer
Janssen Scientific Affairs, LLC

Completed

Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism (BOX-AF)

Atrial Fibrillation

Belgium
University Hospital, Brest

Completed

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study. (PADIS EP)

Pulmonary Embolism

France
University Hospital Inselspital, Berne

Completed

Comparison of Outcomes After Left Atrial Appendage Closure or Oral Anticoagulation in Patients With Atrial Fibrillation

Atrial Fibrillation
AtriCure, Inc.

Completed

Stroke Feasibility Study

Atrial Fibrillation | AFib

United States
Memorial Sloan Kettering Cancer Center

Completed

Patient Factors Impacting Adherence to Oral Chemotherapy

Breast Cancer | Gastrointestinal Cancer

United States
Hoffmann-La Roche

Withdrawn

Postoperative Canadian Oral Anticoagulation Self-management (Post-COAGS) Trial

Cardiovascular Abnormalities

Canada
Meshalkin Research Institute of Pathology of Circulation

Unknown

Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism (PSCAT)

Pulmonary Embolism | Intermediate-high Risk | Combination of Oral Anticoagulation Therapy and Sildenafil

Russian Federation
Mallinckrodt

Completed

Fed Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension

Healthy

United States
Helsinki University Central Hospital
University of Turku

Completed

Non-vitamin K Oral Anticoagulants in Cardioversion (FinCV3)

Atrial Fibrillation
Deutsches Herzzentrum Muenchen

Unknown

Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation (ISAR-TRIPLE)

Coronary Artery Disease | Atrial Fibrillation

Denmark, Germany
University of Padova

Completed

Optimal Duration of Anticoagulation in Deep Venous Thrombosis (MORGAGNI)

Deep Vein Thrombosis of Lower Limb | Lower Extremity Deep Venous Thrombosis Recurrent

Italy
University Hospital Tuebingen
Heart and Diabetes Center North Rhine-Westphalia

Completed

Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2 (POCT-DOAC 2)

Anticoagulation With Direct Oral Anticoagulants
Bristol-Myers Squibb

Completed

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

Atrial Fibrillation
Bristol-Myers Squibb
University Hospital, Gentofte, Copenhagen

Completed

A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

Anticoagulation

Denmark

Search clinical trials for: Adherence to oral anticoagulation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations